InsiderTrades

Form 4 for HALO HALOZYME THERAPEUTICS, INC.

Accepted 2022-02-17 00:00:00 ET · period of report 2022-02-15 · accession 0001179110-22-001391 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-02-17 2022-02-15 HALO Torley Helen Pres, CEO, Dir F - Tax $34.43 -6,892 587.2K -1% -$237.3K
D 2022-02-17 2022-02-15 HALO Torley Helen Pres, CEO, Dir M - OptEx $0.00 +13.1K 594.1K +2% $0
DM 2022-02-17 2022-02-16 HALO Torley Helen Pres, CEO, Dir A - Grant $0.00 +341.1K 84.0K New $0
D 2022-02-17 2022-02-15 HALO Torley Helen Pres, CEO, Dir M - OptEx $0.00 -13.1K 39.3K -25% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-02-15 F D 6,892 $34.43 587,177 D — — (F1) The reported disposition of 6,892 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
2 Common Common Stock 2022-02-15 M A 13,092 $0.00 594,069 D — —
3 Derivative Option to Purchase Common Stock 2022-02-16 A A 257,046 $0.00 257,046 D $34.36 · 2023-02-16 to 2032-02-16 257,046 Common Stock (F3) This option vests one-fourth on such date and then 1/48th monthly thereafter.
4 Derivative Restricted Stock Units 2022-02-15 M D 13,092 $0.00 39,276 D $0.00 · — to — 13,092 Common Stock (F2) This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.
5 Derivative Restricted Stock Units 2022-02-16 A A 84,037 $0.00 84,037 D $0.00 · 2023-02-16 to — 84,037 Common Stock (F4) This award vests one-fourth on the first anniversary of the grant date and then one-fourth on each anniversary date thereafter.